The Ketamine Endgame. Silo Pharmaceutical (SILO).
James Kuo, M.D. the Vice President of R&D for Silo Pharma (SILO) will speak at the 3rd Annual Psychedelic Therapeutics and Drug Development Conference.
Dr....
The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s Novel Topical Ketamine Delivery.
Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side Effects
FT. LAUDERDALE, FL /...
Silo Pharma (SILO) $2.25, Now Our Favorite Psychedelic.
We Liked it at $3.50, we Love it at $2.25.
Down but not out. Now trading below the cash they have in the bank, this...
SILO Pharma (SILO) Gains 53%
For Now, Volatility Remains and the Traders, Seem to be Having the Most Fun.
Silo Pharma Gains 53% Intraday on Patent (Ketamine) Related News
Our opinion...
Adding ATAI (ATAI) to 2024 Watch List. Doubling Down at $1.80, After Anti Depression...
Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm.
Atai was founded in 2018 and went public in June...
Silo Pharma (SILO) Trades up 90% Friday, With 23 Million Shares Traded!
And We Weren't Watching!
It was Friday after all, and the last day of the year, and we were celebrating our 78% gain in Ardelyx...
Latest article
CFO Primer. Tokenize Your Stock?
Had a conversation over Mimosa's Sunday morning with one of our AI Analyst on the tokenization of publicly traded companies, and some interesting information...
Inside the Wild Ride of ATAI (ATAI) $7.22. We’re Up And Out, With a...
Our 6th Billion Dollar Gainer. We're Saying Auf Wiedersehen!
Eli Lilly (LLY) has agreed to pay $6.75 a share in cash upfront ($2.8 billion) –...
AI Meets Mining. MineSignal.AI – Public Inputs – Proprietary Outputs.
MineSignal AI is a technology company that embeds engineers into your business to create and deploy custom AI workflows. It connects directly to your...
